Global Ganja Report

The first decisive step toward the liberalized atmosphere for cannabis across much of the country was quite arguably San Francisco's Proposition P of 1991—the popular initiative that protected medical marijuana use in the city. So it's heartwarming that the City by the Bay has just established an Office of Cannabis to oversee legal sales. 

Three of the Balkan states to emerge from the ashes of Yugoslavia a generation ago are now among the first countries in the ex-communist world to move toward embrace of medical marijuana.

Oregon voted to legalize cannabis way back in November 2014, but promises of state coffers filled with canna-dollars are apparently being held up by an arcane bureaucratic logjam. Newsweek just noted a May 5 report from Oregon's KWG News finding that the state has brought in close to $75 million in cannabis tax revenue since the start of 2016—yet not a penny has gone to actually closing Salem's yawning $1.6 billion budget deficit.

After Colombia's government issued long-awaited regulations on legal cannabis cultivation for the medical market, the southern region of Cauca is anticipating a boom—and a fight for the soul of the nascent industry. On April 10, the Health Ministry released Decree 613, finally implementing Colombia's promised medical marijuana program. The decree guarantees "secure and informed" access to cannabis seeds by licensed companies, fully implementing the program established in principle by Law 1787, passed in July 2016.

It is certainly a sign of the times that a partnership of major California media—led by Bay Area News Group, owner of the San Jose Mercury News—has launched a website entitled The Cannifornian, "Covering the Golden State of Cannabis." That means it's dedicated to reportage on the fast-growing cannabis sector in post-legalization California. An April 25 offering, "Venture capital investors betting big on cannabis," notes that financial consultancy firm New Frontier Data is predicting nationwide legal cannabis sales will balloon to more than $24 billion by 2025.

Prime Minister Justin Trudeau introduced legislation to legalize the recreational use of cannabis in Canada April 13, following through on a campaign pledge and ending a long wait by advocates and entrepreneurs. The new law would allow adults 18 and over to possess or share up to 30 grams of dried herbaceous cannabis, and to purchase cannabis or cannabis oil from retailers, to be regulated at the provincial level. Canadians would also be allowed to grow up to four plants per residence for personal use, and to prepare legal cannabis products at home. Cannabis-infused edibles are to be available for sale after the regulatory framework is developed and brought into force.

The group High NY, "New York's Cannabis Community," hosted an event on "How to Apply Your Skills in the Cannabis Industry" at a Lower Manhattan venue the evening of March 22, featuring speakers with background in the biz from California, Massachusetts and the District of Columbia. Unlike these three polities, New York state has not legalized. But organizers took heart that on that very same day as their meet-up, chronic pain was added to the qualifying conditions under the Empire State's burgeoning if still limited medical marijuana program.

China is to get its first company dedicated to research, development and marketing of medicinal products based on cannabidiol, or CBD. The firm, dubbed XiBiDi Biotechnology Co, is to operate out of Pudong Technology Park, part of the Shanghai Pilot Free-Trade Zone. It will initially offer hemp-derived CBD oil, as well as hemp-based foods and beverages, according to a press release from ChineseInvestors.com, or CIIX. The Chinese character "XiBiDi" is homophonic to "CBD" in English.